Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis

The activity of tigecycline (GAR-936), a novel glycylcycline, was investigated in vitro and in experimental endocarditis due to the susceptible Enterococcus faecalis JH2-2 strain, its VanA type transconjugant BM4316, and a clinical VanA type strain, E. faecium HB217 resistant to tetracycline. MICs o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Lefort, Agnès, Lafaurie, Matthieu, Massias, Laurent, Petegnief, Yolande, Saleh-Mghir, Azzam, Muller-Serieys, Claudette, Le Guludec, Dominique, Fantin, Bruno
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2003
Pynciau:
Experimental Therapeutics
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC148965/
https://ncbi.nlm.nih.gov/pubmed/12499194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.1.216-222.2003
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg